Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

27
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
27
Polygenic Traits01:18

Polygenic Traits

69.3K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
69.3K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

23
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
23
Incomplete Dominance01:43

Incomplete Dominance

30.5K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

20
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elicited Repetitive Daily Blindness Associated With Gain-of-Function <i>SCN1A</i> Variants and Responsiveness to Sodium Channel Blockers.

Neurology. Genetics·2026
Same author

Transition from paediatric to adult care in paediatric-onset neurological disorders in Europe: A survey and scoping review.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same author

Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study.

Epilepsia·2026
Same author

What is the psychological impact on parents of learning about SUDEP? A mixed methods systematic review.

Epilepsy & behavior : E&B·2026
Same author

Artificial intelligence and genomics in paediatric neurology: Promise, pitfalls, and the importance of clinical judgement.

Developmental medicine and child neurology·2025
Same author

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Epilepsy & behavior : E&B·2025

Related Experiment Video

Updated: Feb 20, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.5K

Genetics update: Monogenetics, polygene disorders and the quest for modifying genes.

Joseph D Symonds1, Sameer M Zuberi1

  • 1The Paediatric Neurosciences Research Group, Royal Hospital for Children, Queen Elizabeth University Hospitals, Glasgow, UK; School of Medicine, University of Glasgow, Glasgow, UK.

Neuropharmacology
|October 18, 2017
PubMed
Summary

Genetic channelopathies involve complex genotype-phenotype relationships. This review explores factors influencing these links, discusses gene variation in polygenic diseases, and highlights precision medicine successes in treating conditions like epilepsy.

Keywords:
EpilepsyGenotypeModifierPersonalizedPhenotypePrecision

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.5K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K

Related Experiment Videos

Last Updated: Feb 20, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.5K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.5K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Genetic channelopathies represent a diverse group of diseases arising from ion channel gene mutations.
  • Understanding genotype-phenotype relationships is crucial yet challenging due to phenotypic pleiotropy.
  • Ion channel variation plays a significant role in both monogenic and polygenic disorders.

Purpose of the Study:

  • To provide an overview of factors influencing genotype-phenotype relationships in genetic channelopathies.
  • To explore the role of ion channel variation in polygenic diseases and unravel complex etiologies.
  • To examine the successes and limitations of precision medicine in inherited channelopathies, using epilepsy as a key example.

Main Methods:

  • Literature review focusing on genotype-phenotype correlations in channelopathies.
  • Analysis of factors contributing to the complexity of these relationships.
  • Case examples of specific channelopathies, including voltage-gated sodium channels and epilepsy.

Main Results:

  • Phenotypic pleiotropy in ion channel genes complicates direct genotype-phenotype correlations.
  • Ion channel gene variations are implicated in the etiology of polygenic diseases.
  • Precision medicine approaches show promise for specific genetic channelopathies, particularly epilepsy.

Conclusions:

  • Factors influencing genotype-phenotype relationships in channelopathies are multifaceted.
  • Identifying modifying genes is key to understanding inherited channelopathies.
  • Precision medicine offers targeted therapeutic strategies for select genetic channelopathies, with ongoing challenges.